Data as of Jul 22
| +0.02 / +0.15%|
The 5 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 18.00, with a high estimate of 19.00 and a low estimate of 16.00. The median estimate represents a +32.74% increase from the last price of 13.56.
The current consensus among 7 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.